mHealth Insulin Titration and Management (iSage)

University of Kansas

Status

Completed

Conditions

Type 2 Diabetes Mellitus

Treatments

Other: iSage

Study type

Interventional

Funder types

Other

Identifiers

NCT03704103

STUDY00142758

Details and patient eligibility

About

The purpose of this study is to determine the benefits of using the iSage app for basal insulin titration and support. By doing this study the investigators hope to learn whether the app improves the participant's ability to follow his/her healthcare provider's instructions to adjust his/her insulin doses.

Enrollment

6 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Diagnosed Type 2 Diabetes, based on the World Health Organization (WHO) criteria, treated with basal insulin
HbA1c 8-11% inclusive
Glomerular filtration rate (GFR) > 60 ml/min
Has an Android or iOS based compatible smartphone (iOS 9.0 or above, Android 4.4 or above)
Willing to perform at least 1 fasting finger stick glucose measurements every morning
English speaking

Exclusion criteria

Diagnosis of hypoglycemic unawareness
Diagnosis of hyperglycemic hyperosmolar non-ketotic coma (HONK) or diabetic ketoacidosis (DKA) within 6 months of enrollment
Recent (within the last 6 months)/current use of non-topical steroids
Insulin requirements in excess of 1 U/kg per day
Use of pioglitazone or another thiazolidinedione (TZD)
In the opinion of the provider, HgbA1c goals should be adjusted above 7% due to infirmity, unstable cardiovascular disease, etc.